AU6390894A - Antacid composition and method of production - Google Patents

Antacid composition and method of production

Info

Publication number
AU6390894A
AU6390894A AU63908/94A AU6390894A AU6390894A AU 6390894 A AU6390894 A AU 6390894A AU 63908/94 A AU63908/94 A AU 63908/94A AU 6390894 A AU6390894 A AU 6390894A AU 6390894 A AU6390894 A AU 6390894A
Authority
AU
Australia
Prior art keywords
particles
antacid
antacid composition
aluminum
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63908/94A
Other languages
English (en)
Inventor
Gary G. Liversidge
Gregory L. Mcintire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanosystems LLC
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of AU6390894A publication Critical patent/AU6390894A/en
Assigned to NANOSYSTEMS L.L.C. reassignment NANOSYSTEMS L.L.C. Alteration of Name(s) of Applicant(s) under S113 Assignors: EASTMAN KODAK COMPANY
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU63908/94A 1992-12-11 1993-12-03 Antacid composition and method of production Abandoned AU6390894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11
US989296 1992-12-11
PCT/US1993/011720 WO1994013304A2 (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Publications (1)

Publication Number Publication Date
AU6390894A true AU6390894A (en) 1994-07-04

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63908/94A Abandoned AU6390894A (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Country Status (10)

Country Link
EP (1) EP0673253A1 (ja)
JP (1) JPH08504442A (ja)
KR (1) KR950703982A (ja)
AU (1) AU6390894A (ja)
CA (1) CA2150383A1 (ja)
CZ (1) CZ148695A3 (ja)
FI (1) FI952859A0 (ja)
NO (1) NO952261D0 (ja)
SK (1) SK76595A3 (ja)
WO (1) WO1994013304A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0714240B1 (en) * 1993-08-24 1998-09-23 Kappa Pharmaceuticals Limited Reduced absorption of fatty acids
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
JPWO2016104367A1 (ja) * 2014-12-22 2017-09-28 株式会社Ｌｔｔバイオファーマ 機能性ディスペプシア治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida

Also Published As

Publication number Publication date
FI952859A (fi) 1995-06-09
JPH08504442A (ja) 1996-05-14
SK76595A3 (en) 1997-01-08
NO952261L (no) 1995-06-08
CZ148695A3 (en) 1995-12-13
KR950703982A (ko) 1995-11-17
EP0673253A1 (en) 1995-09-27
FI952859A0 (fi) 1995-06-09
CA2150383A1 (en) 1994-06-23
WO1994013304A3 (en) 1994-09-01
WO1994013304A2 (en) 1994-06-23
NO952261D0 (no) 1995-06-08

Similar Documents

Publication Publication Date Title
EP0644755B1 (en) Surface modified nsaid nanoparticles
US5552160A (en) Surface modified NSAID nanoparticles
EP0812187B1 (en) Solid nanoparticulate pharmaceutical composition
EP0808156B1 (en) Compositions comprising nanoparticles of nsaid
US5622938A (en) Sugar base surfactant for nanocrystals
RU2186562C2 (ru) Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
US5718919A (en) Nanoparticles containing the R(-)enantiomer of ibuprofen
DE69831677T2 (de) Nanokristalline zubereitungen von menschlichen immunschwächevirus (hiv)-protease-in-hibitoren unter verwendung von zellulose-oberflächenstabilisatoren und verfahren zu deren herstellung
HU221586B (hu) Módosított felületű hatóanyag-nanorészecskéket tartalmazó diszperzió, eljárás annak előállítására és az ezt tartalmazó gyógyszerkészítmények
US20030180367A1 (en) Microparticles of water-insoluble substances
HUT65758A (en) Nanogranules containing surface modifier and cloud point modifier and process for production of them
TW201513896A (zh) 醋酸阿比特龍配方
JPH06227968A (ja) ナノ粒子を含む組成物及びその製造方法
HU228849B1 (hu) Fenofibrát-tartalmú, hidrofil polimer oldatával készült szuszpenzió
AU6390894A (en) Antacid composition and method of production
WO1997004756A2 (en) Methacrylate backbone surfactants in nanoparticulate formulations
HUT72052A (en) Antacid compositions and methods of production